Early research (Phase 1)Study completedNCT04477512
What this trial is testing
Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
Who this might be right for
Metastatic Hormone Refractory Prostate Cancer
Washington University School of Medicine 18